Home > Research > Publications & Outputs > The collection of ‘quality’ umbilical cord bloo...

Electronic data

  • Clinical Pragmatism_NGS_Pre-publication

    Rights statement: This is an Accepted Manuscript of an article published by Taylor & Francis in New Genetics and Society on 25/07/2016, available online: http://www.tandfonline.com/doi/full/10.1080/14636778.2016.1209109

    Accepted author manuscript, 467 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

The collection of ‘quality’ umbilical cord blood for stem cell treatments: conflicts, compromises, and clinical pragmatism

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The collection of ‘quality’ umbilical cord blood for stem cell treatments: conflicts, compromises, and clinical pragmatism. / Machin, Laura Louise.
In: New Genetics and Society, Vol. 35, No. 3, 2016, p. 307-326.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Machin LL. The collection of ‘quality’ umbilical cord blood for stem cell treatments: conflicts, compromises, and clinical pragmatism. New Genetics and Society. 2016;35(3):307-326. Epub 2016 Jul 25. doi: 10.1080/14636778.2016.1209109

Author

Bibtex

@article{f17a2abdb9e94b93bb08f6d5992a3d4e,
title = "The collection of {\textquoteleft}quality{\textquoteright} umbilical cord blood for stem cell treatments: conflicts, compromises, and clinical pragmatism",
abstract = "Incentives have been proposed to NHS hospitals to encourage the collection of {\textquoteleft}quality{\textquoteright} umbilical UCB (UCB) to treat people with blood disorders. As UCB is collected immediately after a woman has given birth, maternity practices have come under scrutiny. Sixty-two interviews were conducted between 2009 and 2010 with those working on maternity wards, and in UCB collection and banking. Ethical approval was granted by the university institution and the NHS Research Ethics Committee. Participants perceived a conflict between acquiring a {\textquoteleft}quality{\textquoteright} UCB sample for blood disease sufferers and concerns for maternal and neonatal health. Options to overcome the conflict were compromises that demonstrated that those most powerful in the debates are those conducting maternity practices, whilst those involved in the banking of UCB have less influence perhaps as a consequence of the lower priority of {\textquoteleft}quality{\textquoteright} UCB collection in relation to maternal and neonatal health. ",
keywords = "clinical pragmatism, maternity practices, umbilical cord blood, Qualitative Research",
author = "Machin, {Laura Louise}",
note = "This is an Accepted Manuscript of an article published by Taylor & Francis in New Genetics and Society on 25/07/2016, available online: http://www.tandfonline.com/doi/full/10.1080/14636778.2016.1209109",
year = "2016",
doi = "10.1080/14636778.2016.1209109",
language = "English",
volume = "35",
pages = "307--326",
journal = "New Genetics and Society",
issn = "1463-6778",
publisher = "Routledge",
number = "3",

}

RIS

TY - JOUR

T1 - The collection of ‘quality’ umbilical cord blood for stem cell treatments

T2 - conflicts, compromises, and clinical pragmatism

AU - Machin, Laura Louise

N1 - This is an Accepted Manuscript of an article published by Taylor & Francis in New Genetics and Society on 25/07/2016, available online: http://www.tandfonline.com/doi/full/10.1080/14636778.2016.1209109

PY - 2016

Y1 - 2016

N2 - Incentives have been proposed to NHS hospitals to encourage the collection of ‘quality’ umbilical UCB (UCB) to treat people with blood disorders. As UCB is collected immediately after a woman has given birth, maternity practices have come under scrutiny. Sixty-two interviews were conducted between 2009 and 2010 with those working on maternity wards, and in UCB collection and banking. Ethical approval was granted by the university institution and the NHS Research Ethics Committee. Participants perceived a conflict between acquiring a ‘quality’ UCB sample for blood disease sufferers and concerns for maternal and neonatal health. Options to overcome the conflict were compromises that demonstrated that those most powerful in the debates are those conducting maternity practices, whilst those involved in the banking of UCB have less influence perhaps as a consequence of the lower priority of ‘quality’ UCB collection in relation to maternal and neonatal health.

AB - Incentives have been proposed to NHS hospitals to encourage the collection of ‘quality’ umbilical UCB (UCB) to treat people with blood disorders. As UCB is collected immediately after a woman has given birth, maternity practices have come under scrutiny. Sixty-two interviews were conducted between 2009 and 2010 with those working on maternity wards, and in UCB collection and banking. Ethical approval was granted by the university institution and the NHS Research Ethics Committee. Participants perceived a conflict between acquiring a ‘quality’ UCB sample for blood disease sufferers and concerns for maternal and neonatal health. Options to overcome the conflict were compromises that demonstrated that those most powerful in the debates are those conducting maternity practices, whilst those involved in the banking of UCB have less influence perhaps as a consequence of the lower priority of ‘quality’ UCB collection in relation to maternal and neonatal health.

KW - clinical pragmatism

KW - maternity practices

KW - umbilical cord blood

KW - Qualitative Research

U2 - 10.1080/14636778.2016.1209109

DO - 10.1080/14636778.2016.1209109

M3 - Journal article

VL - 35

SP - 307

EP - 326

JO - New Genetics and Society

JF - New Genetics and Society

SN - 1463-6778

IS - 3

ER -